M&G PLC

Position in MRK — Merck & Co., Inc.

CIK 1802539 London, X0

Position in MRK

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$27,109,002

-$8,742,710 QoQ

Shares Held

210,965

-29.2% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#446

of 3,778 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M&G PLC holds $1,479,850,248 across 11 Drug Manufacturers - General names. MRK ranks #5 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,482,712	$850,011,848
2	BMY	Bristol Myers Squibb Co	5,292,229	$304,938,234
3	ABBV	AbbVie Inc.	579,447	$145,812,043
4	AMGN	Amgen Inc	289,819	$104,949,256
5	MRK	Merck & Co., Inc. This page	210,965	$27,109,002
6	JNJ	Johnson & Johnson	52,505	$13,334,694
7	PFE	Pfizer Inc	418,626	$10,080,514
8	GILD	Gilead Sciences, Inc.	78,527	$9,921,101

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,109,002	210,965	-29.2%	Shares	Defined	2026-08-06
2026-03-31	$35,851,712	298,044	-19.7%	Shares	Defined	2026-05-13
2025-12-31	$39,079,564	371,267	+2.3%	Shares	Defined	2026-02-12
2025-09-30	$30,465,498	362,987	-20.4%	Shares	Defined	2025-11-07
2025-06-30	$36,089,044	455,900	-15.7%	Shares	Sole	2025-08-08
2025-03-31	$48,558,723	540,984	-2.6%	Shares	Sole	2025-05-13
2024-12-31	$55,273,873	555,628	+3.6%	Shares	Sole	2025-02-11
2024-09-30	$60,933,570	536,576	+21.5%	Shares	Sole	2024-10-31
2024-06-30	$54,669,461	441,595	+19.2%	Shares	Sole	2024-07-16
2024-03-31	$48,901,989	370,610	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.